JP2018033454A5 - - Google Patents

Download PDF

Info

Publication number
JP2018033454A5
JP2018033454A5 JP2017161826A JP2017161826A JP2018033454A5 JP 2018033454 A5 JP2018033454 A5 JP 2018033454A5 JP 2017161826 A JP2017161826 A JP 2017161826A JP 2017161826 A JP2017161826 A JP 2017161826A JP 2018033454 A5 JP2018033454 A5 JP 2018033454A5
Authority
JP
Japan
Prior art keywords
seq
humanized anti
amino acid
acid sequence
htfr antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017161826A
Other languages
English (en)
Japanese (ja)
Other versions
JP6993814B2 (ja
JP2018033454A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018033454A publication Critical patent/JP2018033454A/ja
Publication of JP2018033454A5 publication Critical patent/JP2018033454A5/ja
Priority to JP2021200504A priority Critical patent/JP7232889B2/ja
Application granted granted Critical
Publication of JP6993814B2 publication Critical patent/JP6993814B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017161826A 2016-08-25 2017-08-25 抗体融合蛋白質の製造方法 Active JP6993814B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021200504A JP7232889B2 (ja) 2016-08-25 2021-12-10 抗体融合蛋白質の製造方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016164901 2016-08-25
JP2016164901 2016-08-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021200504A Division JP7232889B2 (ja) 2016-08-25 2021-12-10 抗体融合蛋白質の製造方法

Publications (3)

Publication Number Publication Date
JP2018033454A JP2018033454A (ja) 2018-03-08
JP2018033454A5 true JP2018033454A5 (cg-RX-API-DMAC7.html) 2020-06-25
JP6993814B2 JP6993814B2 (ja) 2022-01-14

Family

ID=61246169

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017161826A Active JP6993814B2 (ja) 2016-08-25 2017-08-25 抗体融合蛋白質の製造方法
JP2021200504A Active JP7232889B2 (ja) 2016-08-25 2021-12-10 抗体融合蛋白質の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021200504A Active JP7232889B2 (ja) 2016-08-25 2021-12-10 抗体融合蛋白質の製造方法

Country Status (10)

Country Link
US (1) US11512135B2 (cg-RX-API-DMAC7.html)
EP (1) EP3505538B1 (cg-RX-API-DMAC7.html)
JP (2) JP6993814B2 (cg-RX-API-DMAC7.html)
KR (1) KR102318480B1 (cg-RX-API-DMAC7.html)
CN (1) CN109641971B (cg-RX-API-DMAC7.html)
AU (1) AU2017316955B2 (cg-RX-API-DMAC7.html)
CA (1) CA3034589A1 (cg-RX-API-DMAC7.html)
MX (1) MX389073B (cg-RX-API-DMAC7.html)
SG (1) SG11201901495YA (cg-RX-API-DMAC7.html)
WO (1) WO2018038243A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1247933A1 (en) 2015-06-24 2018-10-05 Jcr Pharmaceuticals Co., Ltd. Fusion protein containing bdnf
CA2990785C (en) 2015-06-24 2024-11-12 Jcr Pharmaceuticals Co., Ltd. ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER
TWI833178B (zh) * 2016-12-26 2024-02-21 日商Jcr製藥股份有限公司 通過血腦障壁之新穎抗人類運鐵蛋白受體抗體
TWI791006B (zh) 2016-12-26 2023-02-01 日商Jcr製藥股份有限公司 包含bdnf之融合蛋白質
WO2019049967A1 (ja) * 2017-09-07 2019-03-14 Jcrファーマ株式会社 水性医薬組成物
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
CN111683972A (zh) * 2018-02-05 2020-09-18 Jcr制药股份有限公司 用于将药剂递送至肌肉的方法
EP3560945A1 (en) * 2018-04-27 2019-10-30 F. Hoffmann-La Roche AG Methods for purification of polypeptides using polysorbates
JP6951051B2 (ja) * 2018-05-24 2021-10-20 HOYA Technosurgical株式会社 吸着剤の生産方法
KR102692543B1 (ko) * 2018-10-26 2024-08-07 재단법인 목암생명과학연구소 Ids를 포함하는 융합 단백질 및 이의 용도
CR20230178A (es) 2020-10-14 2023-07-26 Denali Therapeutics Inc Proteínas de fusión que comprenden enzimas sulfoglucosamina sulfohidrolasa y métodos de estas
JP2024500511A (ja) * 2020-12-23 2024-01-09 広東菲鵬制▲薬▼股▲ふん▼有限公司 抗pd-l1抗体及びその使用
JP2022108271A (ja) * 2021-01-12 2022-07-25 Jcrファーマ株式会社 リガンドと生理活性を有する蛋白質の融合蛋白質をコードする遺伝子が組み込まれた核酸分子
MA71665A (fr) * 2021-02-11 2025-05-30 Denali Therapeutics Inc. Protéines de fusion du récepteur anti-transferrine et leurs procédés d'utilisation
BR112023018268A2 (pt) 2021-03-09 2023-10-31 Japan Chem Res Método para produzir uma proteína de fusão
EP4455290A4 (en) * 2021-12-28 2025-11-26 Japan Chem Res Fusion protein of an anti-transferrin receptor antibody and a bioactive protein for safe gene therapy
WO2024010067A1 (ja) * 2022-07-08 2024-01-11 Jcrファーマ株式会社 中枢神経系疾患の治療のための、核酸分子、ベクター、組換え細胞及び薬剤
TW202542190A (zh) 2023-12-20 2025-11-01 美商戴納立製藥公司 包含酸性α—葡萄糖苷酶之融合蛋白及其方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004271200A1 (en) * 2003-09-05 2005-03-17 Gtc Biotherapeutics, Inc. Method for the production of fusion proteins in transgenic mammal milk
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
CA2591813A1 (en) * 2004-12-21 2006-06-29 Centocor, Inc. Anti-il-12 antibodies, epitopes, compositions, methods and uses
JP5065391B2 (ja) 2006-12-06 2012-10-31 日本ケミカルリサーチ株式会社 ヒトエリスロポエチンの製造方法
EP2114999A2 (en) * 2006-12-12 2009-11-11 Biorexis Pharmaceutical Corporation Transferrin fusion protein libraries
JP2009273427A (ja) 2008-05-16 2009-11-26 Jcr Pharmaceuticals Co Ltd 組換え体ヒトfshの製造方法
EP2350130B1 (en) * 2008-10-31 2018-10-03 Wyeth LLC Purification of acidic proteins using ceramic hydroxyapatite chromatography
JP2013507131A (ja) 2009-10-09 2013-03-04 アーメイゲン・テクノロジーズ・インコーポレイテッド Cnsにおけるイズロン酸2−スルファターゼ活性を増加させるための方法および組成物
WO2012101671A1 (en) * 2011-01-25 2012-08-02 Jcr Pharmaceuticals Co., Ltd. Method for production of human recombinant iduronate 2-sulfatase
US20140335163A1 (en) * 2011-12-01 2014-11-13 Angiochem Inc. Targeted iduronate-2-sulfatase compounds
KR101380740B1 (ko) 2012-06-29 2014-04-11 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 이듀로네이트-2-설파타제의 정제
WO2014016873A1 (en) 2012-07-26 2014-01-30 Jcr Pharmaceuticals Co., Ltd. Method for production of recombinant human alpha-galactosidase a
JP6616189B2 (ja) * 2013-12-25 2019-12-04 Jcrファーマ株式会社 血液脳関門を通過する新規抗トランスフェリン受容体抗体
JP6071018B2 (ja) 2014-10-31 2017-02-01 Jcrファーマ株式会社 組換えヒトDNaseIの製造方法
WO2016116966A1 (en) 2015-01-22 2016-07-28 Jcr Pharmaceuticals Co., Ltd. Method for purification of recombinant human alpha-galactosidase a from material containing contaminant host cell proteins

Similar Documents

Publication Publication Date Title
JP2017176174A5 (cg-RX-API-DMAC7.html)
EA201200277A1 (ru) Антитела против респираторного синцитиального вируса (pcb) и способы их применения
JP2010515717A5 (cg-RX-API-DMAC7.html)
JP2019524645A5 (cg-RX-API-DMAC7.html)
PE20090769A1 (es) Proteinas de union a antigenos que se unen a par-2
JP2012507294A5 (cg-RX-API-DMAC7.html)
JP2010502207A5 (cg-RX-API-DMAC7.html)
EA201291243A1 (ru) Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
JP2018530331A5 (cg-RX-API-DMAC7.html)
RU2015147300A (ru) Гуманизированные антитела к cxcr5, их производные и их применение
JP2012025737A5 (cg-RX-API-DMAC7.html)
JP2005120106A5 (cg-RX-API-DMAC7.html)
JP2012511913A5 (cg-RX-API-DMAC7.html)
JP2013172734A5 (cg-RX-API-DMAC7.html)
EA201190132A1 (ru) Гуманизированные антитела, связывающиеся с cd19, и их применение
JP2015212284A5 (cg-RX-API-DMAC7.html)
JP2018023398A5 (cg-RX-API-DMAC7.html)
JP2015527366A5 (cg-RX-API-DMAC7.html)
WO2008114149A3 (en) Respiratory syncytial virus (rsv) chimeric polypeptide comprising the g protein central region domain located in between the f2 and f1 fusion protein domains
WO2016207304A3 (en) Monoclonal anti-il-1racp antibodies
JP2018537415A5 (cg-RX-API-DMAC7.html)
FI3596125T3 (fi) Anti-PAR2-vasta-aineita ja niiden käyttöjä
JP2013539454A5 (cg-RX-API-DMAC7.html)
RU2018108836A (ru) ВАРИАНТЫ Fc И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
JP2014503198A5 (cg-RX-API-DMAC7.html)